Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

During the Trading Day
4.90 -0.05 / -1.01%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.90 -0.001 / -0.02%
 
Volume: 25.3K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues17.4M31.5M53.8M33.9M
 
 
 
 
 
Cost of Goods Sold8.7M11.7M14.8M11.1M
 
 
 
 
 
Depreciation And Amortization2.0M10.2M18.7M18.4M
 
 
 
 
 
 
Operating ExpensesGross Income6.7M9.6M20.3M4.4M
 
 
 
 
 
General Expenses14.1M15.3M22.9M22.0M
 
 
 
 
 
Research And Development345.6K290.0K2.3M994.0K
 
 
 
 
 
Total Operating Expenses24.8M37.2M56.4M51.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.4M-5.7M-2.5M-17.6M
 
 
 
 
 
Extraordinary Charge----0.00-1.3M
 
 
Interest Expense On Debt2.3M5.3M10.0M9.4M
 
 
 
 
 
Other Expenses-368.1K6.0K-82.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.0M-11.0M-12.6M-28.2M
 
 
 
 
 
Income Taxes-3.7M-655.0K-4.8M-4.6M
 
 
 
 
 
Net Income-6.2M-11.7M-7.8M-23.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.8M38.1M38.3M38.5M
 
 
 
 
 
Shares To Calculate EPS Diluted37.8M38.1M38.3M38.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.31-$0.20-$0.62
 
 
 
 
 
EPS Diluted-$0.16-$0.31-$0.20-$0.62